Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 2Hematologic Neoplasms 2Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1Klebsiella Infections 1Gram-Positive Bacterial Infections 1Febrile Neutropenia 1Escherichia coli Infections 1Bacterial Infections 1Anemia, Refractory, with Excess of Blasts 1

Interventions

gamma-Globulins 1Standard of Care 1Saline Solution 1Piperacillin, Tazobactam Drug Combination 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Bacterial Infections × Piperacillin, Tazobactam Drug Combination × Clear all
NCT00167999 2007-03-15

Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units

Wyeth is now a wholly owned subsidiary of Pfizer

Completed
200 enrolled

Bacterial Infections, Escherichia coli Infections, Klebsiella Infections, Gram-Positive Bacterial Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡